Mitigating the Effects of Nonadherence in Clinical Trials by Preventing Duplicate Subjects in Clinical Trials
Nonadherence in clinical trials remains a significant hurdle, leading to compromised data integrity, skewed results, and costly delays. One often overlooked but critical factor contributing to nonadherence is the presence of duplicate subjects and professional research subjects—individuals who enroll in multiple trials simultaneously or misrepresent their participation history. The Hidden Impact of Duplicate Subjects Nonadherence …